Elo, Petri
Li, Xiang-Guo
Liljenbäck, Heidi
Helin, Semi
Teuho, Jarmo
Koskensalo, Kalle
Saunavaara, Virva
Marjamäki, Päivi
Oikonen, Vesa
Virta, Jenni
Chen, Qingshou
Low, Philip S.
Knuuti, Juhani
Jalkanen, Sirpa
Airas, Laura
Roivainen, Anne https://orcid.org/0000-0002-4006-7977
Funding for this research was provided by:
Jane ja Aatos Erkon Säätiö
Business Finland (632/31/2015)
the Finnish Society of Nuclear Medicine (na)
Turun Yliopistollinen Keskussairaala (ERVA 13303)
European Committee for Treatment and Research in Multiple Sclerosis (na)
Suomen Aivosäätiö (na)
Instrumentariumin Tiedesäätiö (na)
Article History
Received: 21 March 2019
Accepted: 9 October 2019
First Online: 3 December 2019
Ethics approval and consent to participate
: All study protocols and procedures were reviewed and approved by the national Animal Experiment Board of Finland and the Regional State Administrative Agency for Southern Finland (license number ESAVI/3046/04.10.07/2014) and were conducted in accordance with the relevant European Union directive.
: Not applicable.
: The authors declare that they have no competing interests.